Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-25 @ 3:44 AM
NCT ID:
NCT00429702
Eligibility Criteria:
INCLUSION CRITERIA:
* ≥ 8 years of age and \< 19 years of age at the time of registration
* Newly diagnosed with cancer
* Chemotherapy naive
* Scheduled to receive moderately or highly emetogenic chemotherapy (non-steroid containing regimen) as an in-patient. (Refer to Appendix IV. In multiple agent regimens, select the agent with the highest emetic potential.)
* Scheduled for placement of IV accesses device(s) for treatment purposes (allowing a dedicated line for continuous infusion of study agent)
* Not pregnant or lactating
EXCLUSION CRITERIA:
* Prior chemotherapy
* Central Nervous System disease
* Stem cell transplant while on-study
* Out-patient chemotherapy
* Steroids are included in their chemotherapy regimen
* Contraindication to the use of dexamethasone (e.g. diabetes)
* Hepatic and/or renal failure
* Allergic to any of the study medications
* Pregnant or lactating
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
8 Years
Maximum Age:
18 Years
Study:
NCT00429702
Study Brief:
Protocol Section:
NCT00429702